Construction and validation of a prognostic model for 1 year all-cause mortality risk in patients with colorectal cancer liver metastases after HIFU treatment
Clinical and Translational Oncology · 24.03.2026 · 28 (9) · 4032-4041
DOI: 10.1007/s12094-026-04327-3 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Clinical and Translational Oncology, online erschienen am 24.03.2026. Verfasst von Fan Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Suining Central Hospital, Suining, 629000, Sichuan Province, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Nomograms, Colorectal Neoplasms, High-Intensity Focused Ultrasound Ablation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Fund of State Key Laboratory of Ultrasound Medicine and Engineering, Grant from the ultrasound special institutional project of Suining Central Hospital.
Abstract (Originalsprache)
PURPOSE: Colorectal cancer liver metastases (CRLM) worsen the prognosis of patients. High-intensity focused ultrasound (HIFU) is a non-invasive treatment for CRLM, but reliable prognostic tools for HIFU patients are lacking. This study aimed to develop and validate a nomogram to predict the risk of 1-year all-cause mortality (ACM) in patients with CRLM receiving HIFU. METHODS: This retrospective cohort study enrolled patients with CRLM who received HIFU between January 2014 and December 2023 at two medical centers. Data from Chongqing Medical University's Second Affiliated Hospital were used as the training set, while data from Suining Central Hospital were used as the external validation set. Feature selection was performed using the least absolute shrinkage and selection operator (LASSO) regression to identify relevant predictors and establish a nomogram. Model performance was evaluated using receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA). RESULTS: Among 162 patients (121 in the training set, 41 in the validation set), the 1 year ACM rates were 31.4% and 24.4%, respectively. LASSO regression identified six predictors: sex, number of liver metastases, extrahepatic metastases status, number of extrahepatic organs involved, alkaline phosphatase level (ALP), and albumin level (ALB). The nomogram demonstrated robust performance, with an area under the curve (AUC) of 0.886 (95% CI: 0.816-0.956) in the training set and 0.706 (95% CI: 0.495-0.918) in the validation set. Calibration curves showed good agreement, and DCA confirmed its clinical utility. CONCLUSION: A nomogram was developed and externally validated, which provides clinicians with an accurate and reliable tool for individualized prognostic assessment and treatment optimization in patients with CRLM undergoing HIFU.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Suining Central Hospital, Suining, 629000, Sichuan Province, China.
- State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, 400016, China.
- Department of Respiratory and Critical Care Medicine, Suining Central Hospital, Suining, 629000, Sichuan Province, China.
- Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
- Department of HIFU Treatment Center, Suining Central Hospital, Suining, 629000, Sichuan Province, China.
- Department of Oncology, Suining Central Hospital, Suining, 629000, Sichuan Province, China. olxll@163.com.
Förderung
- Fund of State Key Laboratory of Ultrasound Medicine and Engineering
- Grant from the ultrasound special institutional project of Suining Central Hospital
Zitieren
APA
Yang, F., Li, B., Huang, G., Luo, W., Zhang, J., Liu, L., Yang, W., & Li, N. (2026). Construction and validation of a prognostic model for 1 year all-cause mortality risk in patients with colorectal cancer liver metastases after HIFU treatment. Clinical and Translational Oncology, 28(9), 4032-4041. https://doi.org/10.1007/s12094-026-04327-3
Vancouver
Yang F, Li B, Huang G, Luo W, Zhang J, Liu L, et al. Construction and validation of a prognostic model for 1 year all-cause mortality risk in patients with colorectal cancer liver metastases after HIFU treatment. Clinical and Translational Oncology. 2026;28(9):4032-4041. doi:10.1007/s12094-026-04327-3
BibTeX
@article{Yang2026,
author = {Yang, Fan and Li, Bo and Huang, Guohua and Luo, Wen and Zhang, Jiang and Liu, Li and Yang, Wei and Li, Na},
title = {Construction and validation of a prognostic model for 1 year all-cause mortality risk in patients with colorectal cancer liver metastases after HIFU treatment},
journal = {Clinical and Translational Oncology},
year = {2026},
volume = {28},
number = {9},
pages = {4032--4041},
doi = {10.1007/s12094-026-04327-3}
}
EUVIMED